Skip to Content

Tag: Insulet Corp

Also Noted

Insulet sees revenues increase across the board

November 3, 2017HME News Staff

BILLERICA, Mass. - Insulet Corp. reported revenues of $121.8 million for the third quarter of 2017, representing year-over-year growth of 28%. Net loss was 2.2 million. For the Omnipod, revenues in the U.S. were $70.1 million for the quarter, a 17% increase, and, internationally, $32.5 million, a 70% increase. Revenue from drug delivery was $19.2 million, a 19% increase. “We achieved strong third quarter results across all of our businesses, particularly in our international business,”...

Diabetes Technology, Insulet Corp, OmniPod

Read Full Articlered right arrow icon

Also Noted

Insulet sells Neighborhood Diabetes

February 24, 2016HME News Staff

BEDFORD, Mass. - Insulet Corp. has announced plans to sell Neighborhood Diabetes to Liberty Medical for $5 million. Insulet acquired Woburn, Mass.-based Neighborhood Diabetes for $63 million in 2011. "This transaction is an important step in positioning Insulet as a more focused organization, enabling us to direct our operational and financial resources toward driving continued growth of our innovative OmniPod and drug delivery products, while improving our financial profile for profitable growth...

Insulet Corp, Liberty Medical, Neighborhood diabetes

Read Full Articlered right arrow icon